Carregant...
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
The efficacy and safety of OnabotulinumtoxinA 155-195 U (BOTOX(®)) in adults with chronic migraine (CM) were demonstrated in both the Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) studies. However, data about its long-term efficacy and safety in clinical settings are scanty. T...
Guardat en:
| Publicat a: | Springerplus |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4695480/ https://ncbi.nlm.nih.gov/pubmed/26753113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-1636-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|